Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Jan 9;19(3):2053–2061. doi: 10.3892/ol.2020.11282

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright © 2020, Spandidos Publications

PMC Copyright notice

Figure 2. — EV miR101 obtained from BM-MSCs. (A) Expression of miR-101 derived from BM-MSCs (B) or serum EV-miR-101 expression (C) as assessed using reverse transcription-quantitative PCR. The expression of EV-miR-101 in the BM-MSCs was significantly higher in the low-risk MDS group compared with the high-risk MDS group, while cellular miR-101 expression was significantly increased in the high-risk group compared with the low-risk group or normal controls. EV, extracellular vesicle; miR, microRNA; BM-MSCs, bone marrow mesenchymal stromal cells; MDS, myelodysplastic syndrome.

Figure 2. — EV miR101 obtained from BM-MSCs. (A) Expression of miR-101 derived from BM-MSCs (B) or serum EV-miR-101 expression (C) as assessed using reverse transcription-quantitative PCR. The expression of EV-miR-101 in the BM-MSCs was significantly higher in the low-risk MDS group compared with the high-risk MDS group, while cellular miR-101 expression was significantly increased in the high-risk group compared with the low-risk group or normal controls. EV, extracellular vesicle; miR, microRNA; BM-MSCs, bone marrow mesenchymal stromal cells; MDS, myelodysplastic syndrome.